Initially identified in cancer, N2 neutrophils have impaired anti‐tumour capacity and express gene characteristic of alternatively activated M2 macrophages, such as arginase‐1 (Arg1) and mannose receptor C‐type 1 (Mrc1).73 Here, MRC1 is linked to neoplasm.